Compounds > indazoles
Page last updated: 2024-08-21

indazoles and Cancer of Intestines

indazoles has been researched along with Cancer of Intestines in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Park, J; Tanaka, H; Wada, M1
Bao, F; Christiansen, J; Foley, P; Hornby, Z; Luo, D; Maneval, EC; Multani, P; Sigal, D; Tartar, M; Xavier, M1
Ahn, HK; Choi, JY; Choi, SH; Kang, WK; Kim, H; Kim, KM; Lee, J; Lim, HY; Park, JO; Park, SH; Park, YS1
Ha, SY; Heo, JS; Kim, HC; Kim, KM; Kim, ST; Lauwers, G; Lee, J; Park, C; Park, YS1
Atreya, CE; Bergsland, EK; Cives, M; Coppola, D; Hwang, J; Kelley, RK; Morse, B; Nickerson, M; Strosberg, JR; Valone, T; Venook, A; Weber, T1
Allen, E; Hanahan, D; Li, L; Miéville, P; Peng, MW; Saghafinia, S; Warren, CM1
Ali, SM; Amini, B; Elvin, JA; Erlich, RL; Gowen, K; Holmes, O; Meric-Bernstam, F; Miller, V; Piha-Paul, S; Ross, JS; Schrock, AB; Spritz, D; Stephens, PJ; Stockman, DL; Subbiah, V; Suh, JH; Vergilio, JA; Wang, WL; Zarzour, M; Zinner, R1

Trials

2 trial(s) available for indazoles and Cancer of Intestines

ArticleYear
Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours.
    British journal of cancer, 2013, Sep-17, Volume: 109, Issue:6

    Topics: Administration, Oral; Adult; Aged; Angiogenesis Inhibitors; Disease-Free Survival; Female; Humans; Indazoles; Intestinal Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrimidines; Stomach Neoplasms; Sulfonamides; Survival Rate; Treatment Outcome; Young Adult

2013
A phase II study of axitinib in advanced neuroendocrine tumors.
    Endocrine-related cancer, 2016, Volume: 23, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Axitinib; Colonic Neoplasms; Female; Humans; Hypertension; Imidazoles; Indazoles; Intestinal Neoplasms; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Protein Kinase Inhibitors; Rectal Neoplasms; Thymus Neoplasms; Treatment Outcome

2016

Other Studies

5 other study(ies) available for indazoles and Cancer of Intestines

ArticleYear
HASPIN kinase inhibitor CHR-6494 suppresses intestinal polyp development, cachexia, and hypogonadism in Apcmin/+ mice.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2020, Volume: 29, Issue:6

    Topics: Adenomatous Polyposis Coli Protein; Animals; Cachexia; Female; Hypogonadism; Indazoles; Intestinal Neoplasms; Intestinal Polyps; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Serine-Threonine Kinases; Pyridazines

2020
Activity of Entrectinib in a Patient With the First Reported
    Journal of the National Comprehensive Cancer Network : JNCCN, 2017, Volume: 15, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biopsy; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease Progression; Drugs, Investigational; Exons; High-Throughput Nucleotide Sequencing; Humans; Indazoles; Intestinal Neoplasms; Intestine, Small; Low Back Pain; Male; Neoplasm Grading; Neuroendocrine Tumors; Oncogene Proteins, Fusion; Palliative Care; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiotherapy; Response Evaluation Criteria in Solid Tumors; Sequence Analysis, RNA; Treatment Outcome

2017
Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
    Oncotarget, 2016, Jan-26, Volume: 7, Issue:4

    Topics: Adult; Aged; Biomarkers, Tumor; Cohort Studies; Exome; Female; Genome, Human; High-Throughput Nucleotide Sequencing; Humans; Indazoles; Intestinal Neoplasms; Male; Middle Aged; Mutation; Neoplasm Grading; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Proto-Oncogene Proteins B-raf; Pyrimidines; Stomach Neoplasms; Sulfonamides

2016
Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.
    Cell reports, 2016, 05-10, Volume: 15, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Glycolysis; Humans; Imidazoles; Indazoles; Indoles; Intestinal Neoplasms; Lactic Acid; Membrane Transport Proteins; Mice; Models, Biological; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Signal Transduction; Sirolimus; Stomach Neoplasms; Sunitinib; TOR Serine-Threonine Kinases; Up-Regulation

2016
Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion.
    Oncology, 2016, Volume: 91, Issue:6

    Topics: Adolescent; Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Crizotinib; Female; Humans; Indazoles; Intestinal Neoplasms; Liver Neoplasms; Male; Middle Aged; Neuroectodermal Tumors; Oncogene Proteins, Fusion; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Response Evaluation Criteria in Solid Tumors; Sulfonamides; Vascular Endothelial Growth Factor A; Young Adult

2016